Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study

AIM: To demonstrate the non-inferiority (15% non-inferiority limit) of monotherapy with tenofovir disoproxil fumarate (TDF) vs the combination of lamivudine (LAM) plus adefovir dipivoxil (ADV) in the maintenance of virologic response in patients with chronic hepatitis B (CHB) and prior failure with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Manuel, Pascasio, Juan Manuel, Fraga, Enrique, Fuentes, Javier, Prieto, Martín, Sánchez-Antolín, Gloria, Calleja, José Luis, Molina, Esther, García-Buey, María Luisa, Blanco, María Ángeles, Salmerón, Javier, Bonet, María Lucía, Pons, José Antonio, González, José Manuel, Casado, Miguel Ángel, Jorquera, Francisco, Group, the TENOSIMP-B Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685852/
https://www.ncbi.nlm.nih.gov/pubmed/29151700
http://dx.doi.org/10.3748/wjg.v23.i41.7459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685852/
https://www.ncbi.nlm.nih.gov/pubmed/29151700
http://dx.doi.org/10.3748/wjg.v23.i41.7459

Ejemplares similares